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 A mild stress such as brief ischemic episodes may protect the heart from a successive
and more prolonged myocardial ischemia (ischemic preconditioning). This phenomenon
is considered a typical “hormetic mechanism” by which the heart is immunized from
pathological insults such as myocardial ischemia. This mechanism is reduced with aging
and it may be restored and/or preserved by drugs such as adenosine or nicorandil, a mito-
chondrial KATP channels, and lifestyle interventions such as physical activity and/or
hypocaloric diet. Moreover, since the mechanisms involved in cardiac ischemic precondi-
tioning have been established basic and clinical investigators are encouraged to test sev-
eral drug in well-controlled animal and human studies in order to prevent and/or restore
the age-related reduction of ischemic preconditioning.
Key words: hormesis, preconditioning, aging, lifestyles
INTRODUCTION
Ischemic preconditioning (IP) is an adaptive mechanism in response
to brief episodes of myocardial ischemia able to reduce the cellular dam-
age subsequent to a more prolonged ischemic damage firstly described by
Murry et al. (1986). Thus, a brief period of ischemia and the following
reperfusion makes the heart more resistant to successive more prolonged
ischemic insult and it reduces the infarct size (Napoli et al. 2000; Lakatta
and Sollott, 2002; Yellon and Downey, 2003). IP represents a classical
example of hormetic effect of a mild stress (i.e. brief and multiple
ischemic episodes) able to get a protection in the heart against the more
prolonged ischemic insult.
This mechanism does not depend on collateral vessels since it is pres-
ent in animal models without collateral vessel development and in exper-
imental model as in the isolated perfused heart subjected to a global
ischemia (Napoli et al. 2000; Lakatta and Sollott, 2002; Yellon and
Downey, 2003). The protective effect of ischemic preconditioning could
be reduced if the time between preconditioning ischemic episode and
the prolonged ischemic episode is excessive. Finally, ischemic precondi-
tioning is classified in “early” when the protective effect is manifest imme-
diately from ischemic episode and “delayed” when the protective effect is
manifest 24 hours from ischemic episodes (Napoli et al. 2000; Lakatta and
Sollott, 2002; Yellon and Downey, 2003).
IP CLINICAL EQUIVALENTS
Preinfarction angina, warm-up phenomenon, walk-through angina
and transluminal coronary angioplasty are considered clinical equiva-
lents of IP (Napoli et al. 2000; Yellon and Downey, 2003). The incidence
of mortality and cardiogenic shock is reduced in patients with preinfarc-
tion angina (Kloner et al. 1995) and patients with preinfarction angina
treated with thrombolytic therapy showed a more rapid reperfusion and
a reduction of infarct size (Ottani et al. 1995; Andreotti et al. 1996). IP is
clinically involved also in “walk-through angina”, i.e. an effort angina fol-
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lowing physical exercise which paradoxically disappears when the exer-
cise keeps on going, in “warm-up phenomenon”, i.e. a reduction of clin-
ical and electrocardiographic modifications of effort ischemia following
the first exercise test, and “transluminal coronary angioplasty”, i.e. a
reduction of electrocardiographic, biochemical and clinical signs of
ischemia after the first balloon inflation (Napoli et al. 2000; Lakatta and
Sollott, 2002; Yellon and Downey, 2003).
IP MECHANISM
IP is mediated by several agonists (adenosine, norepinephrine,
bradykinin, opioids, ect.) which activate G-protein–coupled receptors
(GPCR) that in turns activate phosphoinositide-3-kinase (PI3K)/serine/
threonine kinase (Akt) with subsequent activation of nitric oxide (NO)
synthase and NO formation, guanylate cyclase, protein kinase G (PKG)
and Protein Kinase C (PKC). Moreover, PKC should be also directly acti-
vated through adenosine or guanylate cyclase by natriuretic peptide
receptor. PKC shifts to _-PKC leading to the opening of the mitochondr-
ial ATP-dependent potassium channels (mitoKATP) that is responsible to
somehow lead to the production of reactive oxygen species (ROS)
(Juhaszova et al. 2005; Downey et al. 2007; Heusch et al. 2008). ROS acti-
vate p38 mitogen-activated kinase and “priming” of mitochondrial per-
meability transition pore (MPTP) is initiated (Juhaszova et al. 2005;
Downey et al. 2007; Heusch et al. 2008). The MPTPs are multiprotein
complexes forming non-selective pores in the inner membrane of the
mitochondria that allows free passage of any molecule which disrupts the
permeability barrier of the inner membrane with devastating conse-
quences related to the uncoupling of the oxidative phosphorylation. The
hypothesis is that IP causes a reversible MPTP opening and a subsequent
mitochondrial depolarization which reduces the driving force for Ca2+
uptake into the matrix which would largely occur during reperfusion
after a prolonged ischemic period (Halestrap et al. 2007; Hausenloy et al.
2009; Zorov et al. 2009). During reperfusion following prolonged
ischemic period, after IP stimulus, reperfusion injury salvage kinase
(RISK) program is activated. It determines the parallel activation of the
PI3K/Akt and the extracellular regulated kinase system with downstream
p70 ribosomal protein S6 kinase (p70S6K) and glycogen synthase kinase
3β (GSK3β) activation leading inhibition of MPTP opening with a reduc-
tion of myocardial cell death (Juhaszova et al. 2005; Downey et al. 2007;
Heusch et al. 2008).
From this mechanism it is clear that the “priming” of MPTP during IP
stimulus represent the “hormetic” mechanism by which IP is able to
inhibit the large MPTP opening during ischemia-reperfusion injury
which represents the key point of cell survival.
P. Abete and others
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AGE-RELATED REDUCTION OF IP
Age-related reduction of IP was firstly obtained in the isolated and
perfused heart model in which a short period of ischemia (2 minutes) fol-
lowed by 10 minutes reperfusion before a prolonged ischemic period (20
minutes) and reperfusion (40 minutes), was able to induce an improve-
ment of left ventricular function in hearts from adult (6 months) but not
in those from senescent rats (24 months) (Abete et al. 1996). Moreover,
the age-related reduction of IP has been confirmed in several studies
(Tani et al. 1997; Fenton et al. 2000; Bartling et al. 2003; Boengler et al.
2007).
This phenomenon has been successively confirmed in clinical studies.
Preinfarction angina, the most evident equivalent of IP, is able to reduce
in-hospital mortality in adult but not in elderly patients (Abete et al.
1997): this result was confirmed by multivariate analysis showing that pre-
infarction angina is protective against mortality only in adult patients
(Abete et al. 1997). The same result was successively confirmed at 5-years
follow-up (Ishihara et al. 2000). Both dynamic electrocardiography
(Napoli et al. 1999) and effort exercise (Longobardi et al. 2000) have
demonstrated that “warm-up phenomenon” is reduced in elderly
patients. Finally, the age-related reduction of IP has been also demon-
strated in elderly patients undergoing coronary angioplasty (Lee et al.
2002) and coronary bypass (Wu et al. 2001).
HYPOTHETICAL MECHANISM OF AGE-RELATED IP REDUCTION
Age-related decline of catecholamines release due to several mecha-
nisms, including a related diminished ability for catecholamine synthesis,
has been described (Mazzeo and Horvarth, 1987; Dawson and Meldrum,
1992). Accordingly, it has been shown that norepinephrine release from
coronary effluent was reduced in senescent hearts in response to IP stim-
ulus (Abete et al. 1996). PKC translocation in response to IP is also
impaired in aging heart and it probably is responsible for the loss of age-
related reduction of IP cardioprotection (Tani et al. 2001). Moreover, p38
MAPK and HSP27 have been demonstrated failing to activate in senes-
cent IP model (Peart et al. 2007). Finally, because an age-related up-regu-
lation of protein phosphatase 2A, an enhanced dephosphorylation by
protein phosphatases has been considered another mechanism of age-
related IP reduction (Fenton et al. 2005).
RE-ESTABLISHMENT OF IP IN THE AGING HEART
Restoring and/or preventing the age-related IP reduction by means
of drugs, acting at different steps of IP mechanism, has been experi-
enced. More importantly, anti-aging interventions, such as exercise train-
ing and caloric restriction have been tested (Pepe, 2001; Jahangir et al.
Ischemic preconditioning in the elderly
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2007). Adenosine (McCully et al. 1998) and the inhibition of phosphatase
(Fenton et al. 2005) are able to restore IP in different senescent experi-
mental model. Interestingly, the effect of IP on developed pressure recov-
ery was absent in sedentary but present in trained senescent hearts
(Abete et al. 2000) and in food-restricted senescent animals (Abete et al.
2002). However, the efficacy of physical activity and caloric restriction was
only partial while it was complete in hearts from combined trained and
food restricted senescent rats (Abete et al. 2005). The approach in restor-
ing age-related IP reduction is more difficult in humans for ethical rea-
sons. In a very important study in elderly patients undergoing coronary
angioplasty the IP impairment was reversed by nicorandil administration,
a specific agonist of mitochondrial KATP channels and its effect was inhib-
ited by the proglibenclamide, a blocker of KATP channels (Lee et al. 2002).
According to animal studies, preinfarction angina, IP clinical equivalent,
was able to reduce mortality in elderly patients only in those with a high
level of physical activity (Abete et al. 2001) as well as in those with normal
body-mass index (BMI) (Abete et al. 2003). Similar to that observed in
animal studies, the effect of physical activity and normal BMI was syner-
gistic. In fact, preinfarction angina reached the maximum protective
effect at highest PASE and lowest BMI score. Interestingly preinfarction
angina is predicitive of mortality in “sedentary overweight” but it is “pro-
tective” in “trained normal weight” elderly patients (Abete et al. 2009).
SUMMARY
Cardiac IP represents the most powerful endogenous protective
mechanism against ischemia through brief episodes of ischemia which
are able to protect the heart against a successive more prolonged
ischemic period. IP represent a classical example of “hormesis”. However,
this powerful protective mechanism is reduced with aging both in exper-
imental and clinical studies. Alterations of mediators release and/or
intracellular pathways may be responsible for age-related ischemic pre-
conditioning reduction. Exercise training and caloric restriction sepa-
rately, and more powerfully taken together, are able to completely pre-
serve and/or restore the age-related reduction of ischemic precondition-
ing. Interestingly, adenosine and nicorandil, an opener of mitochondrial
KATP channels, are able to restore IP in animal and human senescent
models. However, this kind of hormesis is still not ready for application to
humans right now. But, since the complex mechanism of IP is complete-
ly elucidated, development of animal and human studies designed to pre-
serve the efficiency of this cardioprotective mechanism in the aged heart
are required.
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